Jada slowed the bleeding but did not completely stop it [device ineffective].Case narrative: this initial spontaneous report originating from the united states was received from a physician via company representative (reported as "msl") referring to a non-pregnant female patient of an unknown age.The patient's medical history included pregnancy and had delivery.The patient's concurrent conditions, and concomitant medications were not reported.This report concerns 1 patient and 1 device.The physician mentioned that she became aware from an obstetrics and gynaecology (obgyn) colleague, not her patient, that on an unknown date in 2023 (reported as "recently"), the patient was inserted with vacuum-induced hemorrhage control system (jada system) for post-partum hemorrhage (postpartum haemorrhage).The vacuum-induced hemorrhage control system (jada system) slowed the bleeding but did not completely stop it (device ineffective).Patient was taken to interventional radiology (ir) for embolization.The patient sought medical attention.The availability of vacuum-induced hemorrhage control system (jada system) was unknown.For vacuum-induced hemorrhage control system (jada system) lot number and serial number were unknown.Upon internal review, the event of device ineffective was considered to be serious due to required intervention.When the lot number is unknown, a technical investigation of the specific manufacturing process which includes review of records associated with a known lot number cannot be performed.Medical device reporting criteria: serious injury.Fda code: (health effects - health impact per annex f): 4624 surgical intervention (one or more surgical procedures was required, or an existing procedure changed).
|